GoodRx Holdings, Inc. - Common Stock (GDRX)

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock
Shares outstanding
98,685,316
Total 13F shares
121,628,630
Share change
-14,368,664
Total reported value
$536,393,039
Put/Call ratio
44%
Price per share
$4.41
Number of holders
164
Value change
-$65,698,787
Number of buys
98
Number of sells
60

Institutional Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q1 2025

As of 31 Mar 2025, GoodRx Holdings, Inc. - Common Stock (GDRX) was held by 164 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 121,628,630 shares. The largest 10 holders included Francisco Partners Management, LP, VANGUARD GROUP INC, LAKEWOOD CAPITAL MANAGEMENT, LP, AMERIPRISE FINANCIAL INC, Silver Lake Group, L.L.C., Petrus Trust Company, LTA, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, Rip Road Capital Partners LP, and 8 KNOTS MANAGEMENT, LLC. This page lists 166 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.